Clinical trial
Impact of Tight Glycaemic Control in Acute Myocardial Infarction
NCT00237471 · Melbourne Health, Other · Terminated
Key facts
| NCT number | NCT00237471 |
|---|---|
| Title | Impact of Tight Glycaemic Control in Acute Myocardial Infarction |
| Official title | Impact of Tight Glycaemic Control With Insulin on Novel Vascular Disease Risk Factors and Myocardial Function and Perfusion in Acute Myocardial Infarction Patients With Hyperglycaemia |
| Lead sponsor | Melbourne Health, Other |
| Collaborators | National Health and Medical Research Council, Australia Bristol-Myers Squibb Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Myocardial Infarct, Hyperglycemia |
| Intervention type | Drug |
| Interventions | Insulin (tight blood glucose control) |
| Enrollment | 40 |
| Start date | Oct 1, 2005 |
| Primary completion | May 1, 2006 |
| Completion | May 1, 2006 |
| First posted | Oct 12, 2005 |
| Last update posted | Jul 21, 2011 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: